4-CEC Stats & Data

Identity: 4-CEC is the para‑chloro ethyl analogue of cathinone; PubChem lists it under the formula C11H14ClNO and records both free base and HCl salt entries, confirming common naming and salt forms. Adulteration/misrepresentation risk is high: Swiss drug checking reported 4‑CEC being sold as 3‑MMC in December 2024; lab results urged extra caution and adherence to safer‑use tips. Always test before use. Toxicity uncertainty: Very limited human data exist for 4‑CEC; harm‑reduction services note its close structural relation to 4‑CMC (clephedrone), which is suspected to be highly neurotoxic, so conservative dosing and infrequent use are prudent. This is an inference from structural similarity and public health warnings rather than a proven clinical fact. Route risks: Multiple user reports describe severe nasal irritation with 4‑CEC; avoid insufflation if possible. If used intranasally, use tiny lines, rotate nostrils, and rinse with sterile saline after. Inhalation/vaping cautions: Hydrohalide salts of phenethylamines (the class cathinones belong to) can thermally decompose when vaporized, potentially releasing irritant byproducts; if people still choose to vaporize, converting to the freebase is commonly discussed in HR literature, but this carries extra chemistry risks. Safer approach is to avoid vaping unknown salts. Heat, dehydration, and overhydration: As with other stimulants, monitor temperature, take cooling breaks, and follow sensible fluid guidance (roughly 250 mL/hour at rest, up to 500 mL/hour if dancing), as recommended by harm‑reduction groups for cathinones. Testing: Reagent tests cannot prove purity but can help differentiate MDMA from many cathinones; using a panel (Marquis, Froehde, Simon’s, Zimmermann, Morris) improves discrimination within cathinones. Whenever available, seek lab‑grade drug checking. Market context: EMCDDA (EUDA) notes cathinones are frequently mis‑sold as MDMA or other stimulants and appear in powder/tablet forms; treat unknown powders cautiously and avoid polydrug use. Compulsive redosing: Some users report strong urge to redose and extended sessions with chlorinated cathinones; prioritize pre‑measured doses and time limits to curb binges. This is based on anecdotal reports rather than formal dependence data. Post‑use low mood and sleep disruption are commonly reported across cathinones; plan recovery time (nutrition, sleep, hydration) and avoid frequent use.